TrialSignal
Clinical trial intelligence report
Evaluation and Validation of Biological Age as Health Technology
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT04279366-Jul 28, 2026
NCT ID
NCT04279366
Status
COMPLETED
Phase
Completed (Observational Study)
Sponsor
University of Copenhagen
Executive brief
Investment-Ready Snapshot
The study conducted by the University of Copenhagen aims to validate a novel biological age model that could have significant implications for health promotion and lifestyle interventions. Given the increasing global focus on preventive healthcare and personalized medicine, this model could position itself within the burgeoning market for health technology solutions aimed at aging populations. The results may attract interest from health tech companies, insurers, and wellness programs seeking to integrate biological age assessments into their offerings. Competitive implications include potential partnerships or licensing opportunities, as well as the need for thorough diligence on existing patents related to biological age assessment methodologies.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT04279366
Indication
Healthy Aging
Modality
behavioral intervention
Target
Biological age assessment as a health technology, focusing on physiological reserve and functional capacity in comparison to age and sex-matched peers.
Intervention
Lifestyle intervention
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.